Corrigendum to 'Drug metabolism and pharmacokinetic strategies for oligonucleotide- and mRNA-based drug development' Drug Discovery Today 23 (2018) 1733-1745

Drug Discov Today. 2019 Sep;24(9):1953. doi: 10.1016/j.drudis.2018.11.025. Epub 2018 Dec 7.

Authors

Shalini Andersson¹, Madeleine Antonsson¹, Marie Elebring¹, Rasmus Jansson-Löfmark¹, Lars Weidolf²

Affiliations

¹ Drug Metabolism and Pharmacokinetics, Cardiovascular, Renal and Metabolism, Innovative Medicines Biotech Unit, AstraZeneca Gothenburg, SE-43183 Mölndal, Sweden.
² Drug Metabolism and Pharmacokinetics, Cardiovascular, Renal and Metabolism, Innovative Medicines Biotech Unit, AstraZeneca Gothenburg, SE-43183 Mölndal, Sweden. Electronic address: Lars.Weidolf@astrazeneca.com.

PMID: 30529076
DOI: 10.1016/j.drudis.2018.11.025

No abstract available

Publication types

Published Erratum